Health
Genetic test identifies invasive lobular carcinomas that are at high risk of recurring – Medical Xpress
New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is …
New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
Adjuvant treatments, such as chemotherapy, radiation therapy or targeted therapies, are not usually offered to ILC patients after surgery as the disease is slow growing and often responds well to hor…
-
General22 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General23 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
General15 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025